Learn More
Invivogen R848 (Resiquimod), Dual TLR7/TLR8 Agonist, Lyophilized Powder, 1 mg

Supplier: Invivogen TLRLR8481
InvivoGen's R848 (Resiquimod) is a potent TLR7/TLR8 agonist, ideal for immunological research. Supplied as a lyophilized powder in two 500 µg vials, it activates immune cells, enhancing pro-inflammatory cytokine production. Its rigorous testing ensures no contamination with TLR2 or TLR4, making it a reliable tool for studying antiviral and antibacterial immunity, along with vaccine development.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.